BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ault BH. Factor H and the pathogenesis of renal diseases. Pediatric Nephrology 2000;14:1045-53. [DOI: 10.1007/s004670050069] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Herbert AP, Soares DC, Pangburn MK, Barlow PN. Disease-associated sequence variations in factor H: a structural biology approach. Adv Exp Med Biol 2006;586:313-27. [PMID: 16893081 DOI: 10.1007/0-387-34134-X_21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Scobell RR, Kaplan BS, Copelovitch L. New insights into the pathogenesis of Streptococcus pneumoniae–associated hemolytic uremic syndrome. Pediatr Nephrol 2020;35:1585-91. [DOI: 10.1007/s00467-019-04342-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Alexander JJ, Pickering MC, Haas M, Osawe I, Quigg RJ. Complement Factor H Limits Immune Complex Deposition and Prevents Inflammation and Scarring in Glomeruli of Mice with Chronic Serum Sickness. JASN 2004;16:52-7. [DOI: 10.1681/asn.2004090778] [Cited by in Crossref: 45] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
4 Spartà G, Gaspert A, Neuhaus TJ, Weitz M, Mohebbi N, Odermatt U, Zipfel PF, Bergmann C, Laube GF. Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case series. Clin Kidney J 2018;11:479-90. [PMID: 30094012 DOI: 10.1093/ckj/sfy006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Vaziri-sani F, Hellwage J, Zipfel PF, Sjoholm AG, Iancu R, Karpman D. Factor H binds to washed human platelets. J Thromb Haemost 2005;3:154-62. [DOI: 10.1111/j.1538-7836.2004.01010.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
6 Clemenza L, Dieli F, Cicardi M, Salerno A. Research on complement: old issues revisited and a novel sphere of influence. Trends in Immunology 2003;24:292-5. [DOI: 10.1016/s1471-4906(03)00118-2] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
7 Walker PD. Dense deposit disease: new insights: . Current Opinion in Nephrology and Hypertension 2007;16:204-12. [DOI: 10.1097/mnh.0b013e3280bdc0f4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
8 Hoschek JC, Dreyer P, Dahal S, Walker PD. Rapidly progressive renal failure in childhood. American Journal of Kidney Diseases 2002;40:1342-7. [DOI: 10.1053/ajkd.2002.37394] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
9 Licht C, Schlötzer-schrehardt U, Kirschfink M, Zipfel PF, Hoppe B. MPGN II – genetically determined by defective complement regulation? Pediatr Nephrol 2007;22:2-9. [DOI: 10.1007/s00467-006-0299-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
10 Taylor C. Complement factor H and the haemolytic uraemic syndrome. The Lancet 2001;358:1200-2. [DOI: 10.1016/s0140-6736(01)06339-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
11 Boyer O, Noël LH, Balzamo E, Guest G, Biebuyck N, Charbit M, Salomon R, Frémeaux-Bacchi V, Niaudet P. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits. Am J Kidney Dis 2008;51:671-7. [PMID: 18371543 DOI: 10.1053/j.ajkd.2007.11.032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
12 Rusai K, Zaller V, Szilagyi A, Kain R, Prohaszka Z, Cook HT, Aufricht C, Arbeiter K. A rare case: childhood-onset C3 glomerulonephritis due to homozygous factor H deficiency. CEN Case Rep 2013;2:234-8. [PMID: 28509298 DOI: 10.1007/s13730-013-0070-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Bircan Z, Toprak D, Kilicaslan I, Solakoglu S, Uysal V, Ponard D, Turker G. Factor H deficiency and fibrillary glomerulopathy. Nephrology Dialysis Transplantation 2004;19:727-30. [DOI: 10.1093/ndt/gfg605] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
14 Singh AK, Osman AS, Woodiga SA, White P, Mahan JD, King SJ. Defining the role of pneumococcal neuraminidases and O-glycosidase in pneumococcal haemolytic uraemic syndrome. J Med Microbiol 2016;65:975-84. [PMID: 27469261 DOI: 10.1099/jmm.0.000322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
15 Saunders RE, Goodship TH, Zipfel PF, Perkins SJ. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 2006;27:21-30. [PMID: 16281287 DOI: 10.1002/humu.20268] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
16 Cheng ZZ, Hellwage J, Seeberger H, Zipfel PF, Meri S, Jokiranta TS. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. Mol Immunol 2006;43:972-9. [PMID: 16023208 DOI: 10.1016/j.molimm.2005.05.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
17 Smith A, Johnston C, Inverarity D, Slack M, K Paterson G, Diggle M, Mitchell T. Investigating the role of pneumococcal neuraminidase A activity in isolates from pneumococcal haemolytic uraemic syndrome. J Med Microbiol 2013;62:1735-42. [PMID: 23924664 DOI: 10.1099/jmm.0.063479-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
18 Zhang Z, Elsayed AK, Shi Q, Zhang Y, Zuo Q, Li D, Lian C, Tang B, Xiao T, Xu Q, Chang G, Chen G, Zhang L, Wang K, Wang Y, Jin K, Wang Y, Song J, Cui H, Li B. Crucial genes and pathways in chicken germ stem cell differentiation. J Biol Chem 2015;290:13605-21. [PMID: 25847247 DOI: 10.1074/jbc.M114.601401] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.9] [Reference Citation Analysis]
19 Audo I, Bujakowska KM, Léveillard T, Mohand-Saïd S, Lancelot ME, Germain A, Antonio A, Michiels C, Saraiva JP, Letexier M. Development and application of a next-generation-sequencing (NGS) approach to detect known and novel gene defects underlying retinal diseases. Orphanet J Rare Dis. 2012;7:8. [PMID: 22277662 DOI: 10.1186/1750-1172-7-8] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 11.5] [Reference Citation Analysis]
20 Prete M, Indiveri F, Perosa F. Vasculitides: Proposal for an integrated nomenclature. Autoimmunity Reviews 2016;15:167-73. [DOI: 10.1016/j.autrev.2015.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
21 Wang XL, Du Y, Zhao CG, Wu YB, Yang N, Pei L, Wang LJ, Wang QS. Streptococcal pneumonia-associated hemolytic uremic syndrome treated by T-antibody-negative plasma exchange in children: Two case reports. World J Clin Cases 2021; 9(27): 8164-8170 [PMID: 34621876 DOI: 10.12998/wjcc.v9.i27.8164] [Reference Citation Analysis]
22 Mbonu CC, Davison DL, El-Jazzar KM, Simon GL. Clostridium difficile colitis associated with hemolytic-uremic syndrome. Am J Kidney Dis 2003;41:E14. [PMID: 12778432 DOI: 10.1016/s0272-6386(03)00210-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Wen L, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complement deficiency. Journal of Allergy and Clinical Immunology 2004;113:585-93. [DOI: 10.1016/j.jaci.2004.02.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
24 Spinale JM, Ruebner RL, Kaplan BS, Copelovitch L. Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Current Opinion in Pediatrics 2013;25:203-8. [DOI: 10.1097/mop.0b013e32835d7f2c] [Cited by in Crossref: 67] [Cited by in F6Publishing: 23] [Article Influence: 7.4] [Reference Citation Analysis]
25 Hahn H, Um EY, Park YS, Cheong HI. A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H. Pediatr Nephrol 2006;21:295-8. [DOI: 10.1007/s00467-005-2108-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Subramanya A, Houghton D, Watnick S. Steroid-responsive idiopathic glomerular capillary endotheliosis: case report and literature review. Am J Kidney Dis 2005;45:1090-5. [PMID: 15957139 DOI: 10.1053/j.ajkd.2005.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
27 Vaziri-sani F, Holmberg L, Sjöholm A, Kristoffersson A, Manea M, Frémeaux-bacchi V, Fehrman-ekholm I, Raafat R, Karpman D. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney International 2006;69:981-8. [DOI: 10.1038/sj.ki.5000155] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
28 Kaplan BS, Ruebner RL, Spinale JM, Copelovitch L. Current treatment of atypical hemolytic uremic syndrome. Intractable Rare Dis Res. 2014;3:34-45. [PMID: 25343125 DOI: 10.5582/irdr.2014.01001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
29 Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B. Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15. Am J Kidney Dis 2005;45:415-21. [PMID: 15685522 DOI: 10.1053/j.ajkd.2004.10.018] [Cited by in Crossref: 94] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
30 Quigg RJ. Complement and the kidney. J Immunol 2003;171:3319-24. [PMID: 14500622 DOI: 10.4049/jimmunol.171.7.3319] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
31 Ren G, Doshi M, Hack BK, Alexander JJ, Quigg RJ. Rat glomerular epithelial cells produce and bear factor H on their surface that is up-regulated under complement attack. Kidney International 2003;64:914-22. [DOI: 10.1046/j.1523-1755.2003.00188.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
32 Hegasy GA, Manuelian T, Hogasen K, Jansen JH, Zipfel PF. The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. Am J Pathol 2002;161:2027-34. [PMID: 12466119 DOI: 10.1016/S0002-9440(10)64481-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
33 Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney International 2004;65:129-38. [DOI: 10.1111/j.1523-1755.2004.00371.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 4.7] [Reference Citation Analysis]
34 Braun MC, Li L, Ke B, Dubinsky WP, Pickering MC, Chang J. Proteomic Profiling of Urinary Protein Excretion in the Factor H-Deficient Mouse. Am J Nephrol 2006;26:127-35. [DOI: 10.1159/000092211] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
35 Parmeggiani F, Sorrentino FS, Romano MR, Costagliola C, Semeraro F, Incorvaia C, D’Angelo S, Perri P, De Nadai K, Bonomo Roversi E. Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators Inflamm. 2013;2013:435607. [PMID: 24369445 DOI: 10.1155/2013/435607] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
36 Cooper M, McGraw ME, Unsworth DJ, Mathieson P. Familial mesangio-capillary glomerulonephritis with initial presentation as haemolytic uraemic syndrome. Nephrol Dial Transplant 2004;19:230-3. [PMID: 14671063 DOI: 10.1093/ndt/gfg470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
37 Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365:1073-1086. [PMID: 15781103 DOI: 10.1016/s0140-6736(05)71144-2] [Cited by in Crossref: 269] [Cited by in F6Publishing: 536] [Article Influence: 15.8] [Reference Citation Analysis]
38 Nascimento EJ, Silva AM, Cordeiro MT, Brito CA, Gil LH, Braga-Neto U, Marques ET. Alternative complement pathway deregulation is correlated with dengue severity. PLoS One 2009;4:e6782. [PMID: 19707565 DOI: 10.1371/journal.pone.0006782] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 6.2] [Reference Citation Analysis]
39 Ferreira VP, Pangburn MK, Cortés C. Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 2010;47:2187-97. [PMID: 20580090 DOI: 10.1016/j.molimm.2010.05.007] [Cited by in Crossref: 239] [Cited by in F6Publishing: 213] [Article Influence: 19.9] [Reference Citation Analysis]
40 Kamioka I, Nozu K, Fujita T, Kaito H, Tanaka R, Yoshiya K, Iijima K, Nakanishi K, Yoshikawa N, Matsuo M. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr Int 2007;49:196-201. [PMID: 17445038 DOI: 10.1111/j.1442-200X.2007.02352.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 2008;3:249-77. [PMID: 18215115 DOI: 10.1146/annurev.pathmechdis.3.121806.154311] [Cited by in Crossref: 139] [Cited by in F6Publishing: 106] [Article Influence: 9.9] [Reference Citation Analysis]
42 Niaudet P. Syndrome hémolytique et urémique chez l’enfant. EMC - Pédiatrie 2004;1:379-85. [DOI: 10.1016/j.emcped.2004.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Pérez-Caballero D, González-Rubio C, Gallardo ME, Vera M, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 2001;68:478-84. [PMID: 11170895 DOI: 10.1086/318201] [Cited by in Crossref: 211] [Cited by in F6Publishing: 195] [Article Influence: 10.0] [Reference Citation Analysis]
44 Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Frémeaux-Bacchi V. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005;16:555-63. [PMID: 15590760 DOI: 10.1681/ASN.2004050380] [Cited by in Crossref: 362] [Cited by in F6Publishing: 135] [Article Influence: 20.1] [Reference Citation Analysis]
45 Welch TR, Blystone LW. Renal disease associated with inherited disorders of the complement system. Pediatr Nephrol 2009;24:1439-44. [DOI: 10.1007/s00467-008-1027-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
46 Miura T, Goto S, Iguchi S, Shimada H, Ueno M, Nishi S, Narita I. Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation. Clin Exp Nephrol 2011;15:86-91. [PMID: 21057849 DOI: 10.1007/s10157-010-0358-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
47 Welch TR. Complement in glomerulonephritis. Nat Genet 2002;31:333-4. [PMID: 12091912 DOI: 10.1038/ng933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
48 Licht C, Heinen S, Józsi M, Löschmann I, Saunders RE, Perkins SJ, Waldherr R, Skerka C, Kirschfink M, Hoppe B, Zipfel PF. Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int 2006;70:42-50. [PMID: 16612335 DOI: 10.1038/sj.ki.5000269] [Cited by in Crossref: 154] [Cited by in F6Publishing: 131] [Article Influence: 9.6] [Reference Citation Analysis]
49 Mukai S, Hidaka Y, Hirota-kawadobora M, Matsuda K, Fujihara N, Takezawa Y, Kubota S, Koike K, Honda T, Yamauchi K. Factor H gene variants in Japanese: Its relation to atypical hemolytic uremic syndrome. Molecular Immunology 2011;49:48-55. [DOI: 10.1016/j.molimm.2011.07.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
50 Palma LMP, Vaisbich-Guimarães MH, Sridharan M, Tran CL, Sethi S. Thrombotic microangiopathy in children. Pediatr Nephrol 2022. [PMID: 35041041 DOI: 10.1007/s00467-021-05370-8] [Reference Citation Analysis]
51 Watanabe S, Yamaguchi Y, Suzuki T, Ikezoe M, Matsumoto N, Chikamoto H, Nagafuchi H, Horita S, Hattori M, Shiraga H. Inherited factor H dysfunction and complement-associated glomerulonephritis in renal grafts of first and second transplantations. Clin Transplant. 2001;15 Suppl 5:45-50. [PMID: 11791795 DOI: 10.1034/j.1399-0012.2001.0150s5045.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]